Atara Biotherapeutics Announces Third-Quarter 2026 Results
Atara Biotherapeutics announced its third-quarter 2026 financial results and operational progress.
Story updates
09:05:21 PM UTC
SquawkNews
Atara Biotherapeutics 3Q Loss $2.23M >ATRA
09:05:34 PM UTC
SquawkNews
Prescription Drug User Fee Act (PDUFA) Target Action Date of March 31, 2027 Approval of BLA would un